IQVIA Patents – Key Insights and Stats

IQVIA has a total of 595 patents globally, out of which 271 have been granted. Of these 595 patents, more than 51% patents are active. United States Of America is where IQVIA has filed the maximum number of patents, followed by Canada and Europe. Parallelly, United States Of America seems to be the main focused R&D center and is also the origin country of IQVIA.

IQVIA was founded in 1982 by Dennis Gillings. IQVIA provides healthcare research services. The Company offers data science cloud, portfolio management capabilities, commercial effectiveness solutions, managed care, and consumer health services. IQVIA serves pharmaceutical and healthcare industries worldwide. As of April 2022, IQVIA has a market cap of $45.52 Billion.

Do read about some of the most popular patents of IQVIA which have been covered by us in this article and also you can find IQVIA patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over IQVIA patent portfolio.

How many patents does the Founder and CEO of IQVIA have?

The Founder Dennis Gillings and CEO, Ari Bousbib has 0 patents.

How many patents does IQVIA have?

IQVIA has a total of 595 patents globally. These patents belong to 265 unique patent families. Out of 595 patents, 308 patents are active.

How Many Patents did IQVIA File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantIQVIA Applications FiledIQVIA Patents Granted
20104810
20112610
20122115
20134318
20144327
20155120
20161819
20171919
2018817
20191737
20202427
2021924
20222

How many IQVIA patents are Alive/Dead?

Worldwide Patents

How Many Patents did IQVIA File in Different Countries?

Countries in which IQVIA Filed Patents

CountryPatents
United States Of America273
Canada69
Europe66
Japan50
Australia22
Korea (South)14
China11
Germany9
Israel8
United Kingdom6
Spain5
Brazil4
India3
Hong Kong (S.A.R.)2
Mexico2
New Zealand2
France1
Denmark1
Hungary1
Croatia1
Belgium1
Poland1
Lithuania1
Portugal1
Slovenia1

Where are Research Centers of IQVIA Patents Located?

10 Best IQVIA Patent

US6397224B1 is the most popular patent in the IQVIA portfolio. It has received 296 citations so far from companies like International Business Machines and Liberate Technologies.

Below is the list of 10 most cited patents of IQVIA:

Publication NumberCitation Count
US6397224B1296
US20040044673A1149
US6732113B1127
US20160147945A191
US20050197862A189
US7555460B189
US7170446B182
US10586074B277
US20040044556A176
USD525264S176

What Percentage of IQVIA US Patent Applications were Granted?

IQVIA (Excluding its subsidiaries) has filed 4 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 3 have been granted leading to a grant rate of 75.00%.

Below are the key stats of IQVIA patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for IQVIA?

Law FirmTotal ApplicationsSuccess Rate
Fish & Richardson7191.23%
Stevens & Lee6590.20%
Kilpatrick Townsend & Stockton30.00%

EXCLUSIVE INSIGHTS COMING SOON!

What are IQVIA key innovation segments?

What Technologies are Covered by IQVIA?

The chart below distributes patents filed by IQVIA in different countries on the basis of the technology protected in patents. It also represents the markets where IQVIA thinks it’s important to protect particular technology inventions.

R&D Focus: How has IQVIA search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by IQVIA?

Table of Content

Insights you may find interesting

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.